It was hard to miss the headlines out of the recent American College of Cardiology meeting in Chicago: Vytorin, the blockbuster cholesterol drug combination from Merck and Schering-Plough ...

The four lawsuits, which included claims related to both generic Zetia and Vytorin, were subsequently remanded to the jurisdictions in which they were originally filed. "With a view to resolve this ...

Four of the lawsuits also involved Vytorin, a combination drug containing Zetia. The plaintiffs had accused Glenmark of participating in anti-competitive practices in 2010 in a patent dispute ...